Xybion to Present at the Virtual Gravitas Health Reimagined Investor Day
Industry: Apps & Software
Xybion will present at Virtual Gravitas Health Reimagined Investor Day, hosted by Gravitas Securities Inc.
Princeton, NJ (PRUnderground) September 9th, 2021
Xybion Corporation, a global low-code SaaS company that enables digital transformation in highly regulated industries like Life Sciences, is pleased to announce it will be participating in the Virtual Gravitas Health Reimagined Investor Day taking place virtually on Thursday, September 16, 2021.
Dr. Pradip K. Banerjee, Ph.D., Chairman & CEO of Xybion, is scheduled to present on Thursday, September 16, 2021, at 2:00 PM EST. Dr. Banerjee will also be fielding investor questions during the one-day virtual conference hosted by Gravitas Securities Inc. “I look forward to sharing how Xybion is helping enable revolutionary life science companies through their SaaS platform at the Gravitas Health Reimagined Investor Day,” said Dr. Banerjee. Recently, Xybion has entered into a definitive agreement with Gravitas’ inaugural CPC, Gravitas One Capital Corp. (TSXV: GONE.P), along with a go-public financing of C$2.2M.
This year’s Gravitas Health Reimagined Investor Day will feature several leaders in the healthcare space and will be attended virtually by institutional and retail investors from North America and abroad. For additional details about the conference and Gravitas Securities Inc., please visit: www.gravitassecurities.com
Conference Details:
Event: Gravitas Health Reimagined (virtual)
Format: Presentation
Date: Thursday, September 16th, 2021
Time: 11:30AM EST – 4:00PM EST
Registration: Link
About Xybion Corporation
Xybion is a leading SaaS solutions company dedicated to helping life sciences and health systems companies accelerate the conversion of today’s inventions into tomorrow’s approved medicines to save lives and keep employees safe. Through intelligently designed cloud platform we help companies accelerate digital transformation of its processes, speed up innovation, optimize operations, reduce compliance risks, and achieve significant cost savings. Serving more than 160 customers including 100% of the top 20 global biopharmaceutical companies in 25 countries, we have the global scale and expertise to bring employees around the world to help companies in life sciences, healthcare, manufacturing, workplace health, and government. We put our expertise in action every day to help companies transform the digital workplace. Our unique solutions focus on employee health and safety, EHS, integrated preclinical lab management, early-stage drug discovery, digital lab solution, regulatory compliance, GRC, quality management, predictive compliance, content management, and systems validation.
Learn more about Xybion at https://www.xybion.com/
